CIBER-BBN - Industrial Forums

Eleven IndustryAcademic Thematic Forums which have become a meeting point for CIBER-BBN researchers and companies dedicated to a specific sector have been conducted since 2010.

The objective of these meetings is to share information about the interests of the companies and groups of the consortium in the related subjects which allows finding similar and complementary points that favour the establishment of collaborations.

We have organized forums on the following subjects:

ForumDate and UbicationMore Information
Ocular Therapy 2010, June. Instituto de Salud Carlos III, Madrid PDF
Cartilage Therapies  2010, September. Centro de Investigación Médica Aplicada (CIMA), Pamplona PDF
Drug Release Systems 2010, December. Instituto de Salud Carlos III, Madrid PDF
Latest Trends in Clinical Diagnosis  2011, January. Institut de Química Avançada de Catalunya, Barcelona PDF
Biomaterials and Nanostructures in Biomedicine  2011, April. BEK, Bilbao (Imaginenano) PDF
Regenerative Medicine 2011, November. Instituto de Salud Carlos III, Madrid PDF
Biomedical imaging 2012, May. Parc Científic de Barcelona (PCB) PDF Program
New Trends in Nanomedicine for Diagnosis and Therapy in Oncology  2012, October. Parc Científic de Barcelona (PCB) Program
Bone Therapies 2013, May. Instituto de Salud Carlos III, Madrid PDF
Biomedical Monitoring Systems 2013, October. Escuela Nacional de Sanidad, ISCIII, Madrid PDF
Forum on Brain Health and Neurorestoration 2014, September. Barcelona PDF

Format

First session: Brief interventions (5 minutes) of the latest breakthroughs and developments in the research lines developed by the groups and description of the needs and demands of the industry in that sector.

Second session: Company-group bilateral meetings for identifying possible collaborations.

Results

All the forums held achieved success in terms of participation: 10 to 15 companies, and 11 to 19 research groups in each forum. Furthermore, they have been recognized as a good and very useful initiative by the participating researchers and companies. They have also resulted in a good number of collaborations between the research groups and the industries in the form of joint project development and patent licenses.